Jason Weinman
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tomography, X-Ray Computed | 24 | 2024 | 2341 | 2.870 |
Why?
| Lung Diseases, Interstitial | 8 | 2024 | 515 | 1.630 |
Why?
| Glycogen Storage Disease | 4 | 2021 | 20 | 1.130 |
Why?
| Radiation Dosage | 3 | 2023 | 138 | 1.100 |
Why?
| Hypertension, Pulmonary | 7 | 2024 | 1736 | 1.080 |
Why?
| Lung Diseases | 4 | 2022 | 703 | 0.830 |
Why?
| Bronchiolitis Obliterans | 2 | 2021 | 66 | 0.780 |
Why?
| Protein C | 1 | 2021 | 45 | 0.740 |
Why?
| Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 42 | 0.740 |
Why?
| Athetosis | 1 | 2019 | 7 | 0.660 |
Why?
| Thyroid Nuclear Factor 1 | 1 | 2019 | 14 | 0.660 |
Why?
| Chorea | 1 | 2019 | 11 | 0.660 |
Why?
| Congenital Hypothyroidism | 1 | 2019 | 11 | 0.660 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 102 | 0.650 |
Why?
| Pulmonary Eosinophilia | 1 | 2018 | 26 | 0.630 |
Why?
| Silicosis | 1 | 2018 | 21 | 0.630 |
Why?
| Head | 1 | 2019 | 85 | 0.610 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2019 | 102 | 0.600 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2018 | 92 | 0.590 |
Why?
| Child | 26 | 2024 | 18407 | 0.550 |
Why?
| Bronchiolitis | 1 | 2017 | 81 | 0.540 |
Why?
| Bronchiectasis | 3 | 2024 | 107 | 0.530 |
Why?
| Spondylolysis | 1 | 2015 | 7 | 0.500 |
Why?
| Marijuana Smoking | 1 | 2018 | 223 | 0.500 |
Why?
| Imaging, Three-Dimensional | 2 | 2018 | 538 | 0.490 |
Why?
| Heart Defects, Congenital | 5 | 2023 | 665 | 0.440 |
Why?
| Bone Cysts | 1 | 2013 | 11 | 0.430 |
Why?
| Retrospective Studies | 20 | 2024 | 12547 | 0.400 |
Why?
| Infant | 15 | 2024 | 7945 | 0.390 |
Why?
| Humans | 45 | 2024 | 115038 | 0.380 |
Why?
| Computed Tomography Angiography | 2 | 2022 | 99 | 0.380 |
Why?
| Biopsy | 4 | 2018 | 1046 | 0.380 |
Why?
| Lung | 10 | 2024 | 3595 | 0.370 |
Why?
| Pediatrics | 1 | 2019 | 981 | 0.370 |
Why?
| Pulmonary Edema | 2 | 2022 | 116 | 0.350 |
Why?
| Child, Preschool | 13 | 2024 | 9093 | 0.340 |
Why?
| Coronary Vessels | 2 | 2022 | 230 | 0.340 |
Why?
| Altitude Sickness | 2 | 2022 | 172 | 0.320 |
Why?
| Infant, Newborn | 10 | 2023 | 5040 | 0.320 |
Why?
| Respiratory Insufficiency | 2 | 2023 | 290 | 0.310 |
Why?
| Mutation | 4 | 2024 | 3350 | 0.290 |
Why?
| Brain | 1 | 2019 | 2379 | 0.290 |
Why?
| Male | 23 | 2023 | 55729 | 0.280 |
Why?
| Pulmonary Artery | 3 | 2024 | 1028 | 0.270 |
Why?
| Pulmonary Alveoli | 4 | 2021 | 374 | 0.270 |
Why?
| Radiography | 3 | 2018 | 827 | 0.250 |
Why?
| Familial Primary Pulmonary Hypertension | 2 | 2024 | 190 | 0.250 |
Why?
| Female | 22 | 2024 | 59610 | 0.240 |
Why?
| Adolescent | 10 | 2024 | 17862 | 0.240 |
Why?
| Trachea | 3 | 2020 | 234 | 0.230 |
Why?
| Tin | 1 | 2023 | 8 | 0.220 |
Why?
| Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.210 |
Why?
| Pulmonary Atresia | 1 | 2022 | 20 | 0.210 |
Why?
| Abdominal Abscess | 1 | 2022 | 24 | 0.200 |
Why?
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 48 | 0.200 |
Why?
| Pulmonary Veins | 1 | 2023 | 85 | 0.200 |
Why?
| Coronary Circulation | 1 | 2022 | 135 | 0.200 |
Why?
| Social Norms | 1 | 2022 | 20 | 0.200 |
Why?
| Bronchi | 2 | 2023 | 243 | 0.190 |
Why?
| Fractures, Bone | 2 | 2017 | 373 | 0.190 |
Why?
| Sexism | 1 | 2022 | 43 | 0.190 |
Why?
| Pleural Effusion | 1 | 2021 | 47 | 0.190 |
Why?
| Stevens-Johnson Syndrome | 1 | 2021 | 34 | 0.190 |
Why?
| Esophageal Atresia | 1 | 2020 | 25 | 0.180 |
Why?
| Surface-Active Agents | 1 | 2021 | 79 | 0.180 |
Why?
| Vaping | 1 | 2021 | 45 | 0.180 |
Why?
| Tracheoesophageal Fistula | 1 | 2020 | 31 | 0.180 |
Why?
| Cardiac-Gated Imaging Techniques | 1 | 2020 | 16 | 0.180 |
Why?
| Body Surface Area | 1 | 2020 | 27 | 0.180 |
Why?
| Autoimmune Diseases | 1 | 2024 | 394 | 0.180 |
Why?
| Vasculitis | 1 | 2021 | 71 | 0.180 |
Why?
| Joint Diseases | 1 | 2021 | 59 | 0.180 |
Why?
| Hemorrhage | 2 | 2021 | 618 | 0.180 |
Why?
| Mucolipidoses | 1 | 2020 | 7 | 0.180 |
Why?
| Coronary Angiography | 1 | 2022 | 307 | 0.180 |
Why?
| Electronic Nicotine Delivery Systems | 1 | 2021 | 72 | 0.180 |
Why?
| Fracture Healing | 2 | 2017 | 76 | 0.170 |
Why?
| Renal Insufficiency | 1 | 2021 | 136 | 0.170 |
Why?
| Echocardiography | 1 | 2022 | 557 | 0.170 |
Why?
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 520 | 0.160 |
Why?
| Crohn Disease | 1 | 2022 | 196 | 0.160 |
Why?
| Lung Injury | 1 | 2021 | 198 | 0.160 |
Why?
| Death, Sudden | 1 | 2019 | 27 | 0.160 |
Why?
| Altitude | 2 | 2022 | 434 | 0.160 |
Why?
| Signal-To-Noise Ratio | 1 | 2019 | 57 | 0.160 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2023 | 330 | 0.160 |
Why?
| Magnetic Resonance Imaging | 2 | 2023 | 3116 | 0.150 |
Why?
| Bronchioles | 1 | 2018 | 22 | 0.150 |
Why?
| Neuroendocrine Cells | 1 | 2018 | 30 | 0.150 |
Why?
| Respiration Disorders | 1 | 2018 | 68 | 0.150 |
Why?
| Vascular Diseases | 1 | 2020 | 231 | 0.150 |
Why?
| Socioeconomic Factors | 1 | 2022 | 1081 | 0.150 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2024 | 510 | 0.150 |
Why?
| Predictive Value of Tests | 1 | 2022 | 1812 | 0.150 |
Why?
| Pneumonia, Lipid | 1 | 2017 | 3 | 0.150 |
Why?
| Radiation Exposure | 1 | 2017 | 41 | 0.140 |
Why?
| Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| Bronchial Arteries | 1 | 2017 | 11 | 0.140 |
Why?
| Multiple Pulmonary Nodules | 1 | 2017 | 26 | 0.140 |
Why?
| Anti-Asthmatic Agents | 1 | 2021 | 350 | 0.140 |
Why?
| Respiratory Function Tests | 1 | 2018 | 523 | 0.140 |
Why?
| Heart Rate | 1 | 2020 | 705 | 0.140 |
Why?
| Comorbidity | 2 | 2020 | 1457 | 0.140 |
Why?
| Gastrointestinal Diseases | 1 | 2018 | 182 | 0.140 |
Why?
| Airway Obstruction | 1 | 2019 | 168 | 0.140 |
Why?
| Birth Injuries | 1 | 2016 | 11 | 0.140 |
Why?
| Down Syndrome | 1 | 2021 | 335 | 0.140 |
Why?
| Bone Remodeling | 1 | 2017 | 65 | 0.130 |
Why?
| Clavicle | 1 | 2016 | 31 | 0.130 |
Why?
| Upper Extremity | 1 | 2017 | 85 | 0.130 |
Why?
| Reproducibility of Results | 3 | 2022 | 2799 | 0.130 |
Why?
| Anemia, Sickle Cell | 1 | 2019 | 217 | 0.130 |
Why?
| Child Abuse | 2 | 2017 | 451 | 0.120 |
Why?
| Lymphangiectasis | 1 | 2014 | 4 | 0.120 |
Why?
| Lumbosacral Region | 1 | 2015 | 46 | 0.120 |
Why?
| Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.120 |
Why?
| Wounds and Injuries | 1 | 2022 | 723 | 0.120 |
Why?
| Kidney Neoplasms | 1 | 2017 | 328 | 0.110 |
Why?
| Lower Extremity | 1 | 2017 | 337 | 0.110 |
Why?
| Diagnosis, Differential | 1 | 2017 | 1355 | 0.110 |
Why?
| Lumbar Vertebrae | 1 | 2015 | 212 | 0.110 |
Why?
| Humerus | 1 | 2013 | 40 | 0.110 |
Why?
| Femur | 1 | 2013 | 193 | 0.100 |
Why?
| Postoperative Care | 1 | 2013 | 222 | 0.100 |
Why?
| Hypoxia | 1 | 2017 | 958 | 0.090 |
Why?
| Cross-Sectional Studies | 4 | 2022 | 4411 | 0.080 |
Why?
| Heart Failure | 1 | 2021 | 1962 | 0.080 |
Why?
| Bronchoscopy | 2 | 2020 | 244 | 0.080 |
Why?
| Asthma | 1 | 2021 | 2051 | 0.080 |
Why?
| Young Adult | 4 | 2023 | 10498 | 0.060 |
Why?
| Prospective Studies | 3 | 2022 | 6232 | 0.060 |
Why?
| Prognosis | 2 | 2024 | 3334 | 0.060 |
Why?
| Adult | 2 | 2024 | 30654 | 0.060 |
Why?
| T-Box Domain Proteins | 1 | 2024 | 92 | 0.050 |
Why?
| Pandemics | 2 | 2022 | 1321 | 0.050 |
Why?
| Fibrin | 1 | 2023 | 65 | 0.050 |
Why?
| Cellulitis | 1 | 2022 | 45 | 0.050 |
Why?
| Infliximab | 1 | 2022 | 94 | 0.050 |
Why?
| False Positive Reactions | 1 | 2022 | 109 | 0.050 |
Why?
| Necrosis | 1 | 2022 | 210 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2003 | 448 | 0.050 |
Why?
| Granuloma | 1 | 2021 | 85 | 0.040 |
Why?
| Ultrasonography | 1 | 2023 | 636 | 0.040 |
Why?
| Trauma Centers | 1 | 2022 | 325 | 0.040 |
Why?
| Infant, Premature | 1 | 2023 | 477 | 0.040 |
Why?
| Interleukin-1 | 1 | 2003 | 970 | 0.040 |
Why?
| Heart | 1 | 2023 | 610 | 0.040 |
Why?
| Feasibility Studies | 1 | 2022 | 746 | 0.040 |
Why?
| Cardiac Catheterization | 1 | 2022 | 535 | 0.040 |
Why?
| Eosinophils | 1 | 2021 | 281 | 0.040 |
Why?
| Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| Electric Impedance | 1 | 2018 | 98 | 0.040 |
Why?
| Fatal Outcome | 1 | 2019 | 285 | 0.040 |
Why?
| Hyperplasia | 1 | 2018 | 165 | 0.040 |
Why?
| Rare Diseases | 1 | 2018 | 89 | 0.040 |
Why?
| Macrophage Activation Syndrome | 1 | 2017 | 12 | 0.040 |
Why?
| Respiration, Artificial | 1 | 2021 | 526 | 0.040 |
Why?
| Unnecessary Procedures | 1 | 2017 | 43 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2022 | 1715 | 0.040 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2022 | 1138 | 0.040 |
Why?
| Arthritis, Juvenile | 1 | 2017 | 42 | 0.040 |
Why?
| Bony Callus | 1 | 2016 | 7 | 0.030 |
Why?
| Prevalence | 1 | 2023 | 2255 | 0.030 |
Why?
| Ambulatory Care Facilities | 1 | 2018 | 211 | 0.030 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 665 | 0.030 |
Why?
| Observer Variation | 1 | 2016 | 298 | 0.030 |
Why?
| Gestational Age | 1 | 2018 | 758 | 0.030 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 499 | 0.030 |
Why?
| Incidence | 1 | 2020 | 2318 | 0.030 |
Why?
| Colorado | 1 | 2022 | 4089 | 0.030 |
Why?
| Phenotype | 1 | 2018 | 2815 | 0.020 |
Why?
| Chemokines, CXC | 1 | 2003 | 58 | 0.010 |
Why?
| Peroxidase | 1 | 2003 | 157 | 0.010 |
Why?
| Leukocyte Count | 1 | 2003 | 292 | 0.010 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 349 | 0.010 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2003 | 590 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2003 | 1237 | 0.010 |
Why?
| Oxygen | 1 | 2003 | 855 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2003 | 2212 | 0.010 |
Why?
| Neutrophils | 1 | 2003 | 1164 | 0.010 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 1268 | 0.010 |
Why?
| Cells, Cultured | 1 | 2003 | 3896 | 0.010 |
Why?
| Rats | 1 | 2003 | 4973 | 0.010 |
Why?
| Animals | 1 | 2003 | 31867 | 0.000 |
Why?
|
|
Weinman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|